Crowdfunding

We have a gift for your kindness!

Claim Gift

Help more Patients with GEM Subscription

GEM : Give Every Month
GEM is a monthly donation subscription that helps you save patients in India with timely treatment.

Fundraiser ended on Nov 28, 2025

Baby Adwait Cannot Walk, Stand or Run. Help Him!

Baby Adwait Cannot Walk, Stand or Run. Help Him!

SS
Campaigner Details
Impactguru Verified

Shweta Sharma
Delhi Delhi Contact
AH
Beneficiary Details
Impactguru Verified

Adwait Haritas
Child of Shweta Sharma
Patient is currently not admitted

of $ 1,092,896

2,044 Donors
SS
Campaigner Details
Impactguru Verified

Shweta Sharma
Delhi Delhi | Contact
AH
Beneficiary Details
Impactguru Verified

Adwait Haritas
Child of Shweta Sharma
Patient is currently not admitted

Latest Update


Dear Donors,

Adwait, now 1 year old, is bravely battling Spinal Muscular Atrophy (SMA), a rare genetic disorder that weakens his muscles day by day. With regular physiotherapy and Risdiplam medication, his condition is being managed, but these treatments cannot stop the condition from progressing.

Doctors have recommended Zolgensma gene therapy, the only treatment that offers hope for a permanent solution for SMA. However, the cost of this life-saving therapy runs into several crores. We request that you continue supporting Adwait’s treatment. Donate now. Share his story with others. 



Story


“Adwait is a bundle of joy, in its simplest, most beautiful form.” - Shweta (Adwait’s Mom)


When my little boy, Adwait was born, he filled my home with laughter so pure it made my heart ache in the best way. His chubby hands reached for me, his bright eyes full of wonder, and his giggles that I never want to stop hearing.


But something has changed. Slowly, almost subtle at first. Adwait’s energy levels slowly started to decrease each day. His giggles became less free. His cute, bright eyes, once always full of curiosity, seemed a bit, dull...


In my heart, I knew, something wasn’t right.


I took no further chances and took Adwait to Sir Ganga Ram Hospital in Delhi, where the doctors did some physical checks and blood tests. Then, we waited for the results. It wasn’t that long, but my emotions were filled with uncertainty in those moments.


Shortly, doctors called us to explain the reports -


Adiwait has Spinal Muscular Atrophy (SMA), a rare, progressive condition that affects his motor skills.


The wave of anxiety was unreal, but I held my ground. But quickly my 14 months old Adwait’s clumsy hands touched my face and he smiled at me as if he was saying that - “Mumma do not worry”


Adwait’s tiny arms, which once reached eagerly for his favourite toys, now struggle to lift even the lightest ones. Crawling has become harder, and his legs no longer kick with the same excitement. 


Now, Adwait needs a ₹10 CR Drug named Zolgensma. 


What is Zolgensma?


Zolgensma is a drug that can help slow down or even stop the effects of Spinal Muscular Atrophy (SMA), the condition that is making him weaker every day. This drug will give Adwait a future where he can move, play, and grow like other children.


But your support and donations are what my dear boy needs right now. Please Donate!


How to help:


Donate: Click on the ‘Donate Now’ button and help Adwait get the Zolgensma he needs.

Share: Share Adwait’s story with your friends and family, and keep him in your prayers to support him further.


कैसे करें मदद:


दान करें: ‘डॉनट नाउ’ बटन पर क्लिक करें और अद्वैत को जोल्गेन्स्मा की जरूरत है उसे पाने में मदद करें।

शेयर करें: अद्वैत की कहानी अपने दोस्तों और परिवार के साथ साझा करें और उसे आगे समर्थन के लिए अपनी प्रार्थना में रखें।


Disclaimer - 

SMA is a progressive disease that causes Adwait's muscles to weaken over time. To prevent further deterioration and slow the progression, Adwait urgently needs the drug Risdiplam to preserve muscle function only if it is prescribed by the doctor, While the fundraising for Zolgensma is underway, starting Risdiplam immediately is a critical step to safeguard the child’s life and preserve muscle function.

The goal amount of the campaign may be higher than the attached estimates to address and aid the post-hospitalization expenses/contingencies including but not limited to prolonged medication, diagnostics, rehabilitation therapies, and follow-up doctor visits/consultations which vary from disease to disease.
NO INFLUENCE DECLARATION
Impact Guru does not influence / control the decision of the campaigner / patient with respect to choice of hospital / doctor / healthcare treatment or the cost / estimate of any such treatment. Such decision is in entirety of campaigner / patient / beneficiary and / or their family members without any interference and / or say of Impact Guru. Impact Guru is absolved of any liability in respect thereof.
LANGUAGE OF STORY/STATEMENT DECLARATION
The language, story, facts mentioned on this fundraising page is in entirety statements / opinions / thoughts shared by the campaigner / beneficiary or persons authorised on their behalf and shall not be construed as statement / thoughts / opinions of or on behalf of Impact Guru.
TREATMENT COST ESTIMATES
Impact Guru has no control over the cost estimates provided by hospitals / clinics / pharmaceutical companies etc. The cost estimates vary depending on the city and / or hospital where the patient is under treatment, professional fees of the treating doctors, drugs / medicines / therapies chosen for treatment by patient or patient’s family at their own discretion including but not limited to unique medical conditions / circumstances pertaining to each patient.
UTILIZATION OF FUNDS
In the rare scenario of surplus funds remaining within the fundraising campaign due to any of the following circumstances: i) Completion of the Patient's treatment; ii) Receipt of requisite funding for the Patient from alternative sources; iii) Eligibility of the Patient for free treatment under any scheme or the receipt of free treatment by other means; iv) Demise of the Patient; v) Fulfilment of the fundraising campaign's objectives; vi) Termination of the fundraising campaign for any reason; vii) Reduction in the cost of the treatment,
Impact Guru shall have the discretion to use such surplus funds to allocate to i) other patients on Impact Guru for their life-saving treatment and/or donors to provide health benefits with object to maximize social impact; and/or ii) donors of the fundraising campaign at the sole discretion of Impact Guru may be offered the option to claim a pro-rata refund of surplus funds.
PATIENT DEATH UPDATE
Upon the death of the patient, the Campaigner / close relative / POC on behalf of the patient shall be duty bound to inform Impact Guru immediately within two (2) hours of such occurrence and turn off the donations tab (through the internal access granted) on the campaign on Impact Guru Platform in order to stop fundraising on the campaign. In the event Campaigner or authorised/designated POC on behalf of the patient fails to do so and campaign continues raising funds due to such non-information/non action, the Campaigner or authorised/designated POC on behalf of the patient shall be personally liable any consequences thereof; further, Impact Guru shall be disclaimed of all the liabilities occurring with respect to such post death fundraising and the such liability in entirety shall accrue on Campaigner or authorised/designated POC on behalf of the patient. In the event of death of the patient, Impact Guru’s Patient Death Policy at Terms Of Use shall apply.
Documents

Updates(4)


#1 (03 Oct, 2025) - From Shweta Sharma

Dear Donors,

Adwait, now 1 year old, is bravely battling Spinal Muscular Atrophy (SMA), a rare genetic disorder that weakens his muscles day by day. With regular physiotherapy and Risdiplam medication, his condition is being managed, but these treatments cannot stop the condition from progressing.

Doctors have recommended Zolgensma gene therapy, the only treatment that offers hope for a permanent solution for SMA. However, the cost of this life-saving therapy runs into several crores. We request that you continue supporting Adwait’s treatment. Donate now. Share his story with others. 



#2 (29 Jul, 2025) - From Impactguru

Dear Donors, This is an update regarding the funds raised so far. Part of the funds available are being transferred to the personal account to cover the costs incurred for the patient's medical treatment. We thank you for the continuous support on this campaign.

#3 (04 Jul, 2025) - From Impactguru

Dear Donors, This is an update regarding the funds raised so far. Part of the funds available are being transferred to the personal account to cover the costs incurred for the patient's medical treatment. We thank you for the continuous support on this campaign.

#4 (18 Mar, 2025) - From Shweta Sharma

Dear Donors,

Adwait’s body movements are reducing as his muscles are getting weaker due to spinal muscular atrophy. He remains home-bound because of his fragile health. 

Adwait urgently needs Zolgensma, but the cost of the medication is a whopping Rs 10 crore, an amount Adwait’s family can arrange only with your support. 

You can bring hope and a healthier future to Adwait. Every contribution will help him get the treatment he desperately needs. Please donate and share his story to make a difference.

Comment


Top Influencers


Impactguru

Fundraisers for This Cause



Touch more lives with your Kindness !

playstore
X

Access and manage fundraisers at your fingertips!

Get important fundraising tips, a personalized dashboard and real-time updates with ImpactGuru’s new and improved crowdfunding app.

qrcode

Scan the QR code to download the app

mobile-out-image
mobile-inside-image